🔎 Trials Near Me

Dachaigh › Galaran sgamhain eadar-fhillte › Texas

Sgrùdaidhean clionaigeach Galaran sgamhain eadar-fhillte ann an Texas

Tha 18 sgrùdaidhean airson Galaran sgamhain eadar-fhillte a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • Baylor University Medical Center, Dallas
  • Metroplex Pulmonary & Sleep Center, McKinney
  • UT Health San Antonio, San Antonio
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • Baylor College of Medicine, Houston
A’ fastadhÌre 3
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Stryde Research, Carrollton
  • Baylor University Medical Center, Dallas
  • Discovery Clinical Trials, San Antonio
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT05798923

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Houston
  • GSK Investigational Site, Temple
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Denison
  • GSK Investigational Site, El Paso
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • El Paso Pulmonary Association, El Paso
  • Baylor College of Medicine, Houston
  • Baylor Scott and White Health, Temple
A’ fastadhÌre 2
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Houston
A’ fastadhÌre 2
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07333183

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Baylor University Medical Center, Dallas
  • Baylor College of Medicine, Houston
  • Houston Methodist Hospital, Houston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Baylor University Medical Center, Dallas
  • UT Southwest Medical Center Heart and Lung Clinic, Dallas
  • Houston Methodist, Houston
  • agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06388421

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  • University of Texas Southwestern, Dallas
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06855329

Platform Clinical Study for Conquering Scleroderma

  • University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Texas Southwestern, Dallas
  • Baylor University Medical Center at Dallas, Dallas
  • Baylor College of Medicine, Houston
  • agus 2 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 21 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Houston Methodist Hospital, Houston
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Baylor University Medical Center, Dallas
  • UT Southwestern Medical Center-Advanced Lung Clinic, Dallas
  • Houston Methodist Outpatient Center, Houston
  • agus 4 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT05943535

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

  • Baylor College of Medicine/Texas Children'S Hospital, Houston
A’ fastadhSgrùdadh amharc
Suas gu aois 24 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT04098445

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

  • Galderma Investigational Site#7096, Arlington
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Màrt 2026 · NCT07047690

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • University of Texas Southwestern Medical Center, Dallas
  • Metroplex Pulmonary and Sleep Center, McKinney
  • Research Centers of America, McKinney
A’ fastadhÌre 2
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 12 Samh 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Dallas
  • aTyr Investigative Site, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Cèit 2025 · NCT05892614

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.